Omnicare Clinical Research, a leading contract research organization (CRO) operating in 30 countries, provides clinical trials management (Phases I-IV), data analysis and data submission in all major therapeutic categories for the pharmaceutical manufacturers and biotechnology companies.

Moreover, through its Peri-Approval and Geriatric Studies Group, Omnicare's CRO provides the skill sets necessary to assist drug manufacturers in the development of new drugs promoting the well-being of the elderly. As the population ages, there has been heightened development of drugs targeting the diseases of aging. This allows Omnicare's CRO to leverage its network of nursing homes and assisted living investigational sites, as well as its geriatric pharmaceutical expertise.

Omnicare has increased its investment in the CRO business to place greater focus on the biotechnology sector through its Clinimetrics subsidiary. With the mapping of the human genome, drug discovery in this segment has been accelerating resulting in a growing need for clinical trials in this market and a growing need for outsourcing services.

For additional information about Omnicare Clinical Research, visit www.OmnicareCR.com.

For additional information about Clinimetrics, visit www.Clinimetrics.com.